BioCentury
ARTICLE | Company News

Management tracks: Akebia, Sangamo, Bicycle

May 9, 2019 10:11 PM UTC

Kidney disease company Akebia Therapeutics Inc. (NASDAQ:AKBA) said SVP and CMO Rita Jain will step down, effective June 17, to pursue other opportunities. She will be succeeded by Steven Burke, who was SVP and CMO of Proteon Therapeutics Inc. (NASDAQ:PRTO). Akebia also hired Dell Faulkingham as SVP and chief commercial officer. He was SVP and head, U.S. multiple sclerosis franchise at Biogen Inc. (NASDAQ:BIIB).

Sangamo Therapeutics Inc. (NASDAQ:SGMO) said SVP and CMO Edward Conner will resign, effective May 31, to pursue a new opportunity. EVP of R&D Adrian Woolfson will be interim CMO as the genomic therapy company seeks a replacement...